Direct-to-consumer testing will change how medicine is practiced, writes Dr. Matthew S. Davenport.

The 21st Century Cures Act policy granting patients immediate access to their test results has yielded a new symptom: nervous refreshing of the patient portal. Examined in a new JAMA Network Open ...

Precision medicine relies on biomarker testing to match therapies to specific cancers, yet many patients remain untested due to standardization issues. Recommendations include educating clinicians, ...

For stable, symptomatic patients with suspected CAD who are deemed to be at “minimal risk” using a CT-based tool, deferral of diagnostic testing is just as safe as the usual approach and is even ...

Increased patient testing and less lab staff to perform manual tasks have created a bottleneck for care Now, automation found in high-volume labs is accessible no matter a lab’s footprint or volume ...

Where does our liability end and the responsibility to follow up on abnormal test results (including Pap smears and mammograms) reside with our patients? For example, do we need to send certified ...